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Introduction
Case Presentation
Conclusion
• A 62-year-old Caucasian right-handed female with history of hypertension and sinusitis 
presented with 2-month history of bilateral, frontal headaches reaching 5/10 in severity 
with associated nausea, emesis, polydipsia and polyuria. 
• Polyuria occurred every hour while polydipsia included drinking (15-20) 16 oz. bottles 
per day
• She presented to a local hospital and was found to have hypernatremia (Sodium 154 
mEq/mL)
• Non-contrast brain Computerized Tomorgraphy (CT) revealed a 1.2cm x 1.1cm x 1.7 cm 
sellar mass with suprasellar extension
• Urine studies diagnosed central diabetes insipidus, responsive to D-amino D-arginine 
vasopressin (DDAVP). However, she developed seizures and Abducen’s nerve palsy. 
• Magnetic resonance imaging (MRI) of the brain demonstrated intraventricular and 
subarachnoid hemorrhage along with optic nerve edema
• Prior to surgery, she was found on the floor of her room in pool of urine with incoherent 
speech and a sluggish pupillary reflex on right side.
• STAT non-contrast head CT revealed 2.7 x 1.8 x 2.5 cm extension of hemorrhage into 
interpeduncular cisterns and ventricles with associated 3rd ventricle & lateral ventricle. 
There was no midline shift or impending herniation
• She received bi-coronal craniotomy with excision of sellar mass and right frontal 
external ventricular drain placement
• Hydrocephalus and hemorrhage improved on subsequent MRI a few days later
• The pathology report came back positive for a malignant epithelioid neoplasm, 
specifically sellar ATRT, WHO grade V. Tumor was shown to be SMARCB1/INI1 
deficient and no metastatic lesions were found. 
• Recommendations were made for craniospinal radiation and chemotherapy afterward
• She was discharged to facility for radiation therapy. During rehab however, she 
was noted to be less responsive than usual. 
• CTH showed worsening hydrocephalus with IVH and she was transferred to 
HFH
• She underwent Left Frontal VP shunt with EVD placement
• Initial GCS on admission was E2V1TM3
• Her shunt was externalized to facilitate drainage
• There was a deterioration in neurological status and CT head showed new ICH 
related to tumor
• Goals of care discussion lead to terminal extubation
Histology 
MRI
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Figure 2: MRI showing hemorrhage of sellar mass (Red 
arrows) from (A) Sagittal view and (B) Coronal view.
• ATRTs remain rare and aggressive brain tumors seen in both the pediatric and adult 
population
• The management of ATRT remains a difficult challenge with multimodal approaches to 
treatment remaining the mainstay
• Resection followed by radiation and chemotherapy has been shown to significantly 
increase 5-year overall survival rate5 , yet median time to progression remains in the 
range of 6-10 months6.  
• Much more standardization is required in the treatment of disease, since patients 
continue to get variable approaches to treatment
• Additionally, radiation doses and optimal chemotherapy regimens have yet to be 
determined7
• A promising step towards these answers have been in-vitro studies of Insulin-growth 
factor receptor (IGF-1R) inhibition in sensitizing the tumor to chemotherapy and 
radiation8. 
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• Atypical Teratoid Rhabdoid tumors are rare pediatric tumors that usually occur at age <3 
years1
• These tumors are scarcely seen in adults, with the first adult case appearing in 19922
• Since then, about 64 cases have been reported in the literature3
• As such, much what has been learned about adult ATRT cases has come from case reports 
and extrapolation from pediatric cases
• The loss of INI1 (SMARCB1) or BRG1 (SMARCA4) genes are implicated in 
pathogenesis of ATRT3
• Specifically, the INI1/SMARCB1 gene is classified as a tumor-suppressor gene that 
encodes a core subunit protein of the ATP-dependent SWI/SNF chromatin remodeling 
complex4
Figure 1: Rare cells with rhabdoid features (arrow), eccentric nuclei, and 
eosinophilic cytoplasmic hyaline inclusions (hematoxylin-eosin, ×600).9
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